Searched for
LAURUS LABS REVENUE
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore....
- Laurus Labs Q4 Results: Profit soars 3-fold to Rs 234 crore; revenue at Rs 1,440 croreDrug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong...
- Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
- Buy Laurus Labs, target price Rs 710: Bajaj BrokingBajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant g...
- Buy Laurus Labs, target price Rs 480: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 23412.68 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 675: ICICI DirectLaurus Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products, Traded Goods, Contract Service, Other Operating Revenue, Sc...
- Buy Laurus Labs, target price Rs 691: Jefferies GroupFor the quarter ended 31-03-2022, the company has reported a Consolidated Total Income of Rs 1426.12 Crore, up 37.91 % from last quarter To...
- Buy Laurus Labs, target price Rs 590: Edelweiss SecuritiesLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 29552.08 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 670: ICICI DirectLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 28077.03 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 580: Anand RathiLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27017.93 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 670: ICICI DirectLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27635.02 Crore) operating in Pharmaceutica...
- Laurus Labs Q4 results: Net profit zooms nearly 3-fold to Rs 297 crConsolidated revenue from operations of the company stood at Rs 1,411.93 crore for the quarter under consideration. It was Rs 839.14 crore ...
- Buy Laurus Labs, target price Rs 406: ICICI DirectLaurus Labs, incorporated in the year 2005, is a mid cap company with a market cap of Rs 19,588.67 crore, operating in pharmaceuticals sect...
- Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 crThe company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to ...
- Laurus Labs Q2 results: Net profit jumps over four-fold to Rs 242.27 crConsolidated revenue from operations of the company stood at Rs 1,138.84 crore for the quarter under consideration. It was Rs 712.42 crore ...
Load More
